Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Epistaxis Stories

2009-12-06 08:00:00

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally, a potentially life-threatening situation requiring treatment. Research presented today at the 51st Annual Meeting of the American Society of Hematology reveals that the practice of using the anticoagulants aspirin and heparin with the hope of preventing clots in...

2009-12-06 08:00:00

NEW ORLEANS, Dec. 6 /PRNewswire-USNewswire/ -- Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally, a potentially life-threatening situation requiring treatment. Research presented today at the 51st Annual Meeting of the American Society of Hematology reveals that the practice of using the anticoagulants aspirin...

2009-09-02 07:07:00

SOMERSET, N.J., Sept. 2 /PRNewswire/ -- Meda Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, for the treatment of the symptoms of seasonal and perennial allergic rhinitis (SAR and PAR). New ASTEPRO Nasal Spray 0.15% is the first nasal antihistamine to offer convenient once-daily dosing for patients who suffer from seasonal allergies. ASTEPRO Nasal Spray 0.15% relieves rhinitis symptoms,...

2009-01-15 07:00:00

ASTEPRO(TM) (azelastine hydrochloride) Nasal Spray Hits U.S. Pharmacies SOMERSET, N.J., Jan. 15 /PRNewswire/ -- This allergy season, a new medication is available to manage the symptoms of seasonal allergic rhinitis, a condition that impacts as many as 40 million people in the United States. ASTEPRO Nasal Spray contains azelastine in a unique vehicle formulated for enhanced patient benefits. Azelastine is the active ingredient in ASTELIN(R) (azelastine hydrochloride), a leading...

2008-10-31 15:00:26

Vitamin E has been found to decrease cardiovascular risk, but high doses of vitamin E also result in an increase in nose bleeds, U.S. researchers said. Maret Traber of Oregon State University said that vitamin E has been heralded for its ability to reduce the risk of blood clots, heart attack and sudden death, however, vitamin E promotes bleeding by interfering with vitamin K, which is essential in blood clotting. Traber reviewed vitamin E studies and said one of the most compelling...